{"companyId":284390,"requestedLanguage":"ja","resolvedLanguage":"ja","availableLanguages":["en","en-US","ja"],"companyName":"ロケット製薬株式会社","headOfficeLocation":"米国ニュージャージー州クランバリー市シーダーブロック通9番地 08512","presidentName":"ガウラヴ・シャー","companySummary":null,"stockCode":"RCKT","currency":"USD","capital":null,"sales":null,"employees":202,"employeesConsolidated":null,"humanCheck":false,"domains":["rocketpharma.com"],"businessContents":["細胞および遺伝子治療","T細胞エンゲージャー","抗体薬物結合体（ADC）","精密医療","CARVYKTI®","TECVAYLI®","TALVEY®","治癒性遺伝子治療"],"relations":[],"dataSources":[{"detailNumber":1,"url":"https://rocketpharma.wpenginepowered.com/about-us/","scoreAbout":37,"scoreBusiness":27,"scoreGroup":12,"scoreCustomer":4}]}